参天製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2017/04/27 | 1,562 | 1,565 | 1,544 | 1,554 | -15 | -1% | 1,626,000 |
2017/04/26 | 1,577 | 1,595 | 1,558 | 1,569 | +11 | +0.7% | 1,692,200 |
2017/04/25 | 1,570 | 1,576 | 1,555 | 1,558 | -20 | -1.3% | 1,093,900 |
2017/04/24 | 1,578 | 1,584 | 1,565 | 1,578 | +15 | +1% | 1,153,800 |
2017/04/21 | 1,550 | 1,571 | 1,548 | 1,563 | +22 | +1.4% | 1,513,300 |
2017/04/20 | 1,529 | 1,553 | 1,526 | 1,541 | +25 | +1.6% | 1,766,800 |
2017/04/19 | 1,511 | 1,543 | 1,507 | 1,516 | -23 | -1.5% | 2,215,900 |
2017/04/18 | 1,549 | 1,558 | 1,536 | 1,539 | +13 | +0.9% | 1,622,200 |
2017/04/17 | 1,490 | 1,528 | 1,486 | 1,526 | +30 | +2% | 1,183,100 |
2017/04/14 | 1,529 | 1,530 | 1,492 | 1,496 | -24 | -1.6% | 1,314,500 |
2017/04/13 | 1,505 | 1,526 | 1,503 | 1,520 | ±0 | ±0% | 2,196,900 |
2017/04/12 | 1,515 | 1,539 | 1,508 | 1,520 | -1 | -0.1% | 2,177,700 |
2017/04/11 | 1,516 | 1,529 | 1,507 | 1,521 | +20 | +1.3% | 2,743,000 |
2017/04/10 | 1,528 | 1,530 | 1,498 | 1,501 | -16 | -1.1% | 1,989,600 |
2017/04/07 | 1,531 | 1,531 | 1,503 | 1,517 | +5 | +0.3% | 1,723,600 |
2017/04/06 | 1,540 | 1,543 | 1,506 | 1,512 | -29 | -1.9% | 2,322,100 |
2017/04/05 | 1,531 | 1,566 | 1,521 | 1,541 | -18 | -1.2% | 2,721,600 |
2017/04/04 | 1,583 | 1,587 | 1,543 | 1,559 | -52 | -3.2% | 4,298,000 |
2017/04/03 | 1,612 | 1,621 | 1,577 | 1,611 | -1 | -0.1% | 3,012,900 |
2017/03/31 | 1,655 | 1,662 | 1,612 | 1,612 | -42 | -2.5% | 2,014,400 |
2017/03/30 | 1,693 | 1,697 | 1,647 | 1,654 | -16 | -1% | 2,614,700 |
2017/03/29 | 1,696 | 1,700 | 1,668 | 1,670 | -33 | -1.9% | 2,254,900 |
2017/03/28 | 1,691 | 1,713 | 1,685 | 1,703 | +25 | +1.5% | 1,572,500 |
2017/03/27 | 1,690 | 1,705 | 1,673 | 1,678 | +2 | +0.1% | 1,750,500 |
2017/03/24 | 1,657 | 1,680 | 1,652 | 1,676 | +27 | +1.6% | 929,900 |
2017/03/23 | 1,641 | 1,656 | 1,633 | 1,649 | +3 | +0.2% | 1,356,400 |
2017/03/22 | 1,648 | 1,661 | 1,645 | 1,646 | -32 | -1.9% | 1,344,200 |
2017/03/21 | 1,692 | 1,700 | 1,657 | 1,678 | +17 | +1% | 1,920,000 |
2017/03/17 | 1,640 | 1,671 | 1,632 | 1,661 | +1 | +0.1% | 2,544,100 |
2017/03/16 | 1,655 | 1,663 | 1,648 | 1,660 | -7 | -0.4% | 940,200 |
2017/03/15 | 1,670 | 1,671 | 1,651 | 1,667 | -4 | -0.2% | 691,100 |
2017/03/14 | 1,670 | 1,678 | 1,655 | 1,671 | +9 | +0.5% | 1,029,600 |
2017/03/13 | 1,636 | 1,667 | 1,636 | 1,662 | +26 | +1.6% | 955,200 |
2017/03/10 | 1,638 | 1,647 | 1,629 | 1,636 | +16 | +1% | 2,142,200 |
2017/03/09 | 1,641 | 1,641 | 1,618 | 1,620 | -13 | -0.8% | 1,138,500 |
2017/03/08 | 1,641 | 1,641 | 1,628 | 1,633 | -8 | -0.5% | 1,448,400 |
2017/03/07 | 1,632 | 1,644 | 1,619 | 1,641 | +5 | +0.3% | 881,200 |
2017/03/06 | 1,624 | 1,644 | 1,617 | 1,636 | +5 | +0.3% | 988,700 |
2017/03/03 | 1,637 | 1,642 | 1,624 | 1,631 | -8 | -0.5% | 1,542,300 |
2017/03/02 | 1,641 | 1,644 | 1,626 | 1,639 | +12 | +0.7% | 1,677,200 |
2017/03/01 | 1,613 | 1,632 | 1,607 | 1,627 | +17 | +1.1% | 1,297,600 |
2017/02/28 | 1,639 | 1,642 | 1,607 | 1,610 | -24 | -1.5% | 1,856,400 |
2017/02/27 | 1,615 | 1,640 | 1,610 | 1,634 | +13 | +0.8% | 1,576,400 |
2017/02/24 | 1,631 | 1,632 | 1,606 | 1,621 | -17 | -1% | 1,353,500 |
2017/02/23 | 1,598 | 1,639 | 1,590 | 1,638 | +39 | +2.4% | 1,876,500 |
2017/02/22 | 1,628 | 1,630 | 1,594 | 1,599 | -34 | -2.1% | 2,279,600 |
2017/02/21 | 1,623 | 1,633 | 1,609 | 1,633 | +10 | +0.6% | 1,103,800 |
2017/02/20 | 1,604 | 1,626 | 1,594 | 1,623 | -2 | -0.1% | 1,306,300 |
2017/02/17 | 1,610 | 1,631 | 1,595 | 1,625 | -14 | -0.9% | 2,183,600 |
2017/02/16 | 1,635 | 1,643 | 1,626 | 1,639 | -1 | -0.1% | 1,495,500 |
1851~
1900
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「参天薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
参天薬 | 167,000円 | 0.0% | +50.6% | 2.04% | 17.79倍 | 2.00倍 |
|
緑内障、加齢黄斑変性、ドライアイ治療薬など眼科用医薬品首位。一般用目薬「サンテ」が有名 |
小野薬 | 174,700円 | -3.5% | -50.2% | 4.58% | 14.15倍 | 1.05倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
ロート | 280,800円 | +18.2% | +4.2% | 1.18% | 19.90倍 | 2.54倍 |
|
一般用医薬品の目薬で世界首位。「肌研」が急成長しスキンケアが柱に。アジアなど海外積極進出 |
ツムラ | 485,800円 | +22.6% | +68.1% | 2.80% | 12.94倍 | 1.25倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
久光薬 | 427,700円 | +7.3% | -3.8% | 2.10% | 19.85倍 | 1.15倍 |
|
貼る鎮痛消炎剤首位。医療用シェア5割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
市場注目の銘柄
チャート関連のコラム